Pharmacological strategies to prevent restenosis: Lessons learned from blockade of the renin-angiotensin system

Circulation

Volumn 93, Issue 5, 1996, Pages 848-852

  Pratt, R E ^a   Dzau, V J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

angioplasty; angiotensin; atherosclerosis receptors; Editorials; stenosis

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 2 ETHYL 5,7 DIMETHYL 3 [4 [2 (2H TETRAZOL 5 YL)PHENYL]BENZYL]IMIDAZO[4,5 B]PYRIDINE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE;

ANGIOPLASTY; ANIMAL MODEL; CELL CYCLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; DRUG MECHANISM; EDITORIAL; ENZYME INHIBITION; HUMAN; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATOR GENE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESTENOSIS; TREATMENT OUTCOME; VASCULAR SMOOTH MUSCLE;

EID: 0029962758     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.5.848     Document Type: Editorial

References (0)